1. Use of Magnetic Resonance Imaging as Well as Clinical Disease Activity in the Clinical Classification of Multiple Sclerosis and Assessment of Its Course: A Report from an International CMSC Consensus Conference, March 5-7, 2010.
- Author
-
Cook, Stuart D., Dhib-Jalbut, Suhayl, Dowling, Peter, Durelli, Luca, Ford, Corey, Giovannoni, Gavin, Halper, June, Harris, Colleen, Herbert, Joseph, Li, David, Lincoln, John A., Lisak, Robert, Lublin, Fred D., Lucchinetti, Claudia F., Moore, Wayne, Naismith, Robert T., Oehninger, Carlos, Simon, Jack, and Sormani, Maria Pia
- Subjects
MULTIPLE sclerosis diagnosis ,MAGNETIC resonance imaging ,CONFERENCES & conventions ,BIOMARKERS ,CENTRAL nervous system ,MULTIPLE sclerosis ,NUCLEAR magnetic resonance spectroscopy ,DISEASE relapse ,CONTRAST media - Abstract
It has recently been suggested that the Lublin-Reingold clinical classification of multiple sclerosis (MS) be modified to include the use of magnetic resonance imaging (MRI). An international consensus conference sponsored by the Consortium of Multiple Sclerosis Centers (CMSC) was held from March 5 to 7, 2010, to review the available evidence on the need for such modification of the Lublin-Reingold criteria and whether the addition of MRI or other biomarkers might lead to a better understanding of MS pathophysiology and disease course over time. The conference participants concluded that evidence of new MRI gadolinium-enhancing (Gd+) T1-weighted lesions and unequivocally new or enlarging T2-weighted lesions (subclinical activity, subclinical relapses) should be added to the clinical classification of MS in distinguishing relapsing inflammatory from progressive forms of the disease. The consensus was that these changes to the classification system would provide more rigorous definitions and categorization of MS course, leading to better insights as to the evolution and treatment of MS. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF